Probiotix Health Plc (LSE:PBX) has achieved a decisive operational and financial inflection point, transitioning into statutory EBITDA profitability while accelerating commercial partnership revenues across international healthcare markets. The life sciences company discovers and commercialises patented probiotic formulations. The company's lead commercial asset, Lactobacillus plantarum …
Poolbeg Pharma plc (LSE:POLB) has maintained active clinical development momentum across its diversified portfolio of therapeutic candidates targeting severe hyperinflammation, cancer immunotherapy complications, and infectious diseases. The clinical-stage biopharmaceutical company utilizes a capital-light, fast-track development model. By leveraging human challenge trial data and artificial …
hVIVO plc (LSE:HVO) has solidified its global market leadership in human challenge clinical trials, completing the operational expansion and commercial ramp-up of its state-of-the-art quarantine trial facility in Canary Wharf, London. Quoted on the AIM market of the London Stock Exchange, the specialist contract …
Cambridge Nutritional Sciences PLC (LSE:CNSL) has accelerated its strategic repositioning to capture growing international demand for personalised health, nutrition, and food intolerance diagnostics. The company—formerly known as Omega Diagnostics Group PLC—has finalised its operational transition from a diversified point-of-care medical testing group into a …
Coiled Therapeutics PLC (LSE:COIL) has advanced its focused biopharmaceutical development operations, concentrating scientific resources on early-stage target validation and preclinical candidate nomination across high-unmet-need therapeutic indications. The development-stage life sciences company investigates novel biological pathways and molecular targets implicated in chronic inflammatory, fibrotic, and …
Creo Medical Group plc (LSE:CREO) has maintained steady commercial momentum across international surgical markets by driving clinical adoption of its proprietary CROMA advanced energy platform. The Welsh medical device company develops minimally invasive electrosurgical devices for endoscopy. Its patented CROMA platform uniquely combines bipolar …
ConvaTec Group Plc (LSE:CTEC) has demonstrated consistent top-line revenue expansion and operating margin progression by executing its FISBE (Focus, Innovate, Simplify, Build, Execute) operational framework. The global medical products company commands leading market positions across four core chronic care categories: Advanced Wound Care, Ostomy …
Diaceutics PLC (LSE:DXRX) has accelerated its commercial revenue scaling across the global pharmaceutical sector by providing enterprise data analytics and diagnostic commercialisation solutions. The Belfast-headquartered health technology company addresses a profound commercial bottleneck in precision medicine: ensuring patients receive timely, accurate diagnostic biomarker testing …
ECO Animal Health Group PLC (LSE:EAH) has accelerated its commercial and clinical investments in veterinary pharmaceuticals and biological vaccines designed to protect livestock health and enhance agricultural productivity. The London-headquartered animal health specialist develops, manufactures, and markets treatments for pork and poultry producers worldwide. …
EKF Diagnostics Holdings plc (LSE:EKF) has reinforced its operational momentum across global clinical healthcare markets by driving volume expansion in point-of-care testing and contract life-sciences manufacturing. The Cardiff-headquartered medical diagnostics business designs, manufactures, and distributes diagnostic analysers and consumables for blood glucose, haemoglobin, and …